Providers Clinical Support System - Medications for Opioid Use Disorders (PCSS-MOUD)
The Providers Clinical Support System - Medications for Opioid Use Disorders (PCSS-MOUD) is a SAMHSA funded national training, guidance, and clinical mentoring program to enhance the capacity of healthcare and counseling professionals to identify and treat opioid use disorder (OUD).
Training Support for Practitioners
PCSS-MOUD provides free training to health professionals to provide effective, evidence-based, medication treatments to patients with opioid use disorder in primary care, psychiatric care, substance use disorder treatment, and pain management settings. The training increases healthcare providers’ knowledge and skills in the prevention, identification, and treatment of substance use disorder (SUD) with a focus OUD.
Events and Resources
SAMHSA’s PCSS-MOUD hosted a webinar on Inequities in Black People Accessing and Receiving Substance Use Treatment. The webinar, led by Dr. Michelle P. Durham, addresses systemic inequities that Black individuals face in accessing substance use treatment. It highlights issues of systemic racism and discrimination, that are linked to U.S. drug policies and the War on Drugs. Dr. Durham advocates for culturally responsive treatment approaches and emphasizes the importance of social determinants of health.
The webinar explores the psychological impact of these challenges and offers innovative strategies for creating equitable treatment environments. It empowers healthcare providers to advocate for systemic changes in healthcare and the criminal justice system, ultimately inspiring action for a more just and equitable future. The webinar aims to:
- Describe racial inequities in substance use disorders.
- Review federal and state policies that influenced the criminalization of substance use.
- List individual and programmatic strategies to decrease inequities in treating substance use disorders.
Credit Designations Available: AMA PRA Category 1 Credit™, Nursing Contact Hour(s), Pharmacy CE Credit, AAPA Category 1 CME Credit, Social Work CE Credit, and IPCE Credit
The PCSS-MOUD Exchange is a four-session course focused on the implementation of prescribing medications for treating opioid use disorder (MOUD) in a variety of healthcare settings. PCSSMOUD-X is intended for an interprofessional audience. Prescribers with frontline experience prescribing MOUD and developing clinic workflows will be available during all four sessions to answer participants’ questions and discuss real-world cases.
The PCSS-MOUD Exchange four-session series will consist of four weekly sessions, taking place every Wednesday at 3:00 pm EST. The next series will begin in February 2025. Please stay tuned for registration links and updates in the upcoming months.
Credit Designations Available: AMA PRA Category 1 Credit™, Nursing Contact Hours, AAPA Category 1 CME credit, and Interprofessional Continuing Education (IPCE) credit. Note: A Certificate of Attendance which acknowledges 1 hour of participation is also available (0 CE).
PCSS-MOUD recently launched a new and exciting 8-part podcast series that delves into the critical importance of harm reduction. This series consists of 30-minute episodes hosted by distinguished members of the Association for Multidisciplinary Education and Research in Substance Use and Addiction (AMERSA). Each episode will feature experts across different fields, providing a well-rounded perspective on the topic.
Mentoring Support for Practitioners
The PCSS-MOUD mentoring program is a national network of trained clinicians with expertise in treating substance use disorders, co-occurring mental disorders, and pain management. There are three levels of mentoring support.
- Discussion Forum moderated by addiction specialists, where health professionals can post questions and receive answers from clinical experts and other colleagues.
- Ask a Clinical Question provides a simple and direct way for practitioners to receive answers related to substance use disorder, opioid use disorder, and other related topics via email.
- One-on-One Mentoring provides individualized guidance via email, phone or in-person (if possible) on specific clinical questions.
SAMHSA funds the PCSS-MOUD to provide practitioner training in the evidence-based prevention and treatment of SUD. The trainings must apply for DEA registrations to prescribe Schedule II-V medications as directed in Section 1263 of the Consolidated Appropriations Act (PDF | 3.7 MB), known as the Medication Access and Training Expansion (MATE) Act.
Payment Program for Rural Health Clinics
In June 2021, the Health Resources & Services Administration (HRSA) launched a Payment Program for Rural Health Clinics to improve access to medications for opioid use disorder treatment by paying for providers, who obtained a waiver to prescribe buprenorphine.
Get answers to frequently asked questions about the DATA 2000 Waiver Training Payment Program.
Rural Health Clinics (RHCs) still have the opportunity to apply for a $3,000 payment on behalf of each provider who trained to obtain the waiver necessary to prescribe buprenorphine after January 1, 2019. Approximately $1.2 million in program funding remains available for RHCs and will be paid on a first-come, first-served basis until funds are exhausted.
Please contact DATA2000WaiverPayments@hrsa.gov for questions regarding this payment program.
For More Information
Read the FY 2023 Cooperative Agreement Notice of Funding Opportunity (NOFO).
SAMHSA Point of Contact: fola.kayode@samhsa.hhs.gov.